Long-Term Follow-Up of the VIALE-A Study: Survival Outcomes and Subgroup Analysis in Newly Diagnosed AML Patients Ineligible for Intensive Induction Treated With Venetoclax + Azacitidine | VuMedi

Find latest AML videos · 300+ videos

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

10 seconds

Playback speed

Long-Term Follow-Up of the VIALE-A Study: Survival Outcomes and Subgroup Analysis in Newly Diagnosed AML Patients Ineligible for Intensive Induction Treated With Venetoclax + Azacitidine

By Walter Fiedler

131 views

February 24, 2025

Comments 0

Login to view comments. Click here to Login